IL-17A, a major proinflammatory cytokine, can be produced by a variety of leukocytes, but its exact cellular source in human inflammatory diseases remains incompletely understood. IL-17A protein is abundantly found in mast cells in human tissues, such as inflamed synovium, but surprisingly, mechanistic murine studies failed to demonstrate IL-17A production by mast cells. Here, we demonstrate that primary human tissue mast cells do not produce IL-17A themselves but actively capture exogenous IL-17A through receptor-mediated endocytosis. The exogenous IL-17A is stored in intracellular granules and can subsequently be released in a bioactive form. This novel mechanism confers to mast cells the capacity to steer IL-17A-mediated tissue inflammation by the rapid release of preformed cytokine.

, ,
doi.org/10.1189/jlb.3HI1215-542R, hdl.handle.net/1765/97383
Journal of Leukocyte Biology
Department of Pediatrics

Noordenbos, T. (Troy), Blijdorp, K., Chen, S. (Sijia), Stap, J., Mul, E. (Erik), Cañete, J.D. (Juan D.), … Baeten, D. (2016). Human mast cells capture, store, and release bioactive, exogenous IL-17A. Journal of Leukocyte Biology, 100(3), 453–462. doi:10.1189/jlb.3HI1215-542R